Concepedia

Marcin L. Leja

ML

Statistics

Publications

9

Citations

333

H-Index

9

Active since

2016

Affiliations

Postgraduate School of Molecular Medicine(Current)

Medical University of Warsaw

University of Information Technology and Management in Rzeszow

Institute of Physiology and Pathology of Hearing

Danylo Halytsky Lviv National Medical University

Marcin L. Leja is an author at Postgraduate School of Molecular Medicine specializing in cancer pharmacology, medicine, and anticancer activity.

ORCID

Publications per year

2016–2023

9

Publications

9

Study of novel anticancer 4-thiazolidinone derivatives

Konrad A. Szychowski, Marcin L. Leja, Danylo Kaminskyy et al. · Chemico-Biological Interactions · 2016 · 92 citations

, , +9

Tetrabromobisphenol A (TBBPA)-stimulated reactive oxygen species (ROS) production in cell-free model using the 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA) assay—limitations of method

Konrad A. Szychowski, Kamila Rybczyńska‐Tkaczyk, Marcin L. Leja et al. · Environmental Science and Pollution Research · 2016 · 75 citations · Full text

, , +17

Anticancer properties of 4-thiazolidinone derivatives depend on peroxisome proliferator-activated receptor gamma (PPARγ)

Konrad A. Szychowski, Marcin L. Leja, Danylo Kaminskyy et al. · European Journal of Medicinal Chemistry · 2017 · 54 citations

, , +11

Cytotoxic effects of two extracts from garlic (Allium sativum L.) cultivars on the human squamous carcinoma cell line SCC-15

Konrad A. Szychowski, Urszula E. Binduga, Kamila Rybczyńska‐Tkaczyk et al. · Saudi Journal of Biological Sciences · 2016 · 28 citations · Full text

, , +9

Anticancer properties of 5Z-(4-fluorobenzylidene)-2-(4-hydroxyphenylamino)-thiazol-4-one

Konrad A. Szychowski, Danylo Kaminskyy, Marcin L. Leja et al. · Scientific Reports · 2019 · 26 citations · Full text

, , +13

1–5 of 9